Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pneumoperitoneum × Therapeutics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 44 Neoplasms 39 Fatigue 29 Depression 25 Prostatic Neoplasms 20 Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, Follicular 16 Carcinoma, Non-Small-Cell Lung 15 Multiple Myeloma 14 Lymphoma, Large B-Cell, Diffuse 14 Lung Neoplasms 14 Colorectal Neoplasms 14 Pain 13 Lymphoma, Non-Hodgkin 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Lymphoma, B-Cell, Marginal Zone 12 Leukemia, Myeloid, Acute 12 Hodgkin Disease 12 Burkitt Lymphoma 12 Lymphoma, Large-Cell, Immunoblastic 11 Anxiety Disorders 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic-Phase 10 Leukemia, Hairy Cell 10 Blast Crisis 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 9 Leukemia, Myeloid, Accelerated Phase 9 Head and Neck Neoplasms 9

Interventions

Therapeutics 1 Surgical Instruments 1 Sodium Chloride 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01868347 2013-06-06

OPERA

University of Turin, Italy

Phase 3 Unknown

Pneumoperitoneum

Data powered by HemOnc (CC BY 4.0) Colophon ⚡